Helping customers understand the safety and efficacy of their drug in patients. **Learn more about the central lab below or advance to the next page to move on to the GMP lab**
Our award-winning preclarus solutions provide access to real-time lab data for investigator sites, project teams and customers through portals and dashboards.
For our central lab, Preclarus is an invaluable solution to maximize the time and resources of your study while ensuring its quality.
Pharmaceutical development is evolving rapidly and with it the demand for high-quality laboratory services continues to grow. PPD® Laboratories’ central lab provides standardized testing, consistent results and innovative data solutions across a wide range of technologies and applications for all phases of pharmaceutical development.
Our locations in Asia, Europe and North America ensure customers have access to central lab services, regardless of where study sites are located.
NeoGenomics is a leading provider of cancer-focused genetic testing, pathology testing, and interpretation services backed by strong scientific expertise and experience. NeoGenomics’ capabilities and service offerings complement those of PPD Laboratories. Together, PPD and NeoGenomics provide a comprehensive clinical trial and drug development service offering for the oncology continuum.
Without Preclarus, data sets from individual lab locations must be standardized before they can be combined, an expensive and time-consuming task. With the Preclarus central lab database, data standardization and reconciliation happen automatically, eliminating the need to merge and harmonize data from different systems and saving hundreds of hours at the end of the trial.
Interested in learning more? Contact us
